Interestingly, expression of PTEN and the level of FOXO1 in the nucleus inversely correlate with RUNX2 expression in prostate cancer specimens from patients with lymph nodes or bone metastasis [55]. The gene discussed is RUNX2; the disease is prostate carcinoma.